Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Article title: An affinity threshold for maximum efficacy in anti-PD-1 immunotherapy
Authors: Sarah C. Cowles, Allison Sheen, Luciano Santollani, Emi A. Lutz, Brianna M. Lax, Joseph R. Palmeri, Gordon J. Freeman, K. Dane Wittrup
Journal: mAbs
DOI: https://doi.org/10.1080/19420862.2022.2088454
It has been noted by the authors that Figure 1a was published with an error. Sequencing confirmed that the antibody CDRH1 for all the proteins produced for this work is GYTFTSHFIH, with the exception of the highest affinity mutant, as noted in Figure 1a. This corrected CDRH1 sequence is the same as the original 29F.1A12 sequence discovered in the Freeman Lab. The correction has not changed the interpretation or original conclusions of the article. The authors apologize for any inconvenience caused.NEW Figure 1: